Taysha Gene Therapies Inc (NASDAQ: TSHA) is -6.36% lower on its value in year-to-date trading and has touched a low of $1.19 and a high of $4.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TSHA stock was last observed hovering at around $1.70 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $1.62, the stock is -0.18% and -5.44% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.12 million and changing -4.71% at the moment leaves the stock -27.13% off its SMA200. TSHA registered -35.20% loss for a year compared to 6-month loss of -26.36%.
The stock witnessed a 5.88% gain in the last 1 month and extending the period to 3 months gives it a -25.69%, and is -1.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.61% over the week and 8.98% over the month.
Taysha Gene Therapies Inc (TSHA) has around 52 employees, a market worth around $332.00M and $9.91M in sales. Profit margin for the company is -229.67%. Distance from 52-week low is 36.13% and -62.50% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.23%).
The EPS is expected to shrink by -1.54% this year
The shares outstanding are 204.94M, and float is at 157.66M with Short Float at 15.27%.
The top institutional shareholder in the company is FMR LLC with over 21.21 million shares valued at $$47.51 million. The investor’s holdings represent 9.1103 of the TSHA Shares outstanding. As of 2024-06-30, the second largest holder is RTW INVESTMENTS, LP with 18.8 million shares valued at $$42.11 million to account for 8.075 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 18.65 million shares representing 8.0104 and valued at over $$41.78 million, while BLACKROCK INC. holds 5.0778 of the shares totaling 11.74 million with a market value of $$26.3 million.
Taysha Gene Therapies Inc (TSHA) Insider Activity
The most recent transaction is an insider purchase by Manning Paul B, the company’s 10% Owner. SEC filings show that Manning Paul B bought 1,333,333 shares of the company’s common stock on Jun 27 ’24 at a price of $2.25 per share for a total of $3.0 million. Following the purchase, the insider now owns 1.33 million shares.
